ANA Investigates

In this episode, we'll delve into the medically and legally complex topic of cannabis. The legal landscape around marijuana has changed in the US in the past 15 years. Many of our patients now have legal access to products derived from cannabis, and they are turning to physicians for advice on whether these products can treat their neurologic conditions. Products derived from cannabis have been st...

This is an exciting time in the treatment of neurologic disease -- a period of rapid innovation and discovery. And, as a result, more and more academic neurologists and neuroscientists are partnering with the corporate world and others to bring their discoveries to market. On this episode of ANA investigates, Dr. Clifton Gooch, Professor and Chair of Neurology at the Morsani College of Medicine at...

This month we'll have the first episode exploring the career paths of some of the most inspiring leaders in our field. During ANA2019, Dr. Romer Geocadin interviewed Dr. Walter Koroshetz, the Director of the NINDS about his journey. Dr. Koroshetz's shares insights and give advice for those that wish to follow in his footsteps. Series 1, Episode 5

This month we'll explore a topic that's more social science than neuroscience. We address implicit bias, explicit bias and our ability to change each of our biases. Dr. Jim Siegler, assistant professor of neurology at Cooper University interviews Dr. Allison Willis, associate professor of neurology and epidemiology at University of Pennsylvania Perelman School of Medicine. Series 1, Episode 4.

This month, we'll have part two of our two-part series on unbiased diagnostics in neurologic disease. As you may remember from our first episode, UCSF neurohospitalist Megan Richie interviewed Dr. Michael Wilson, a neuro-immunologist at UCSF, about a technique called metagenomic next generation sequencing, or mNGS. mNGS is a way of searching all of the genetic material in a CSF sample for the pres...

This episode is the first of a two-part episode on unbiased diagnostics in neurologic disease. In this episode, UCSF's Dr. Megan Richie sat down with UCSF's Dr. Michael Wilson, a neuro-immunologist specializing in infectious diseases of the central nervous system. They spoke about the unbiased technique called metagenomic next generation sequencing, or mNGS, a technique developed through the UCSF...

At a time when support for basic and translational science needs a strong voice and the burden of neurological disease is growing, the ANA is the champion of neurological research and the ally of all physicians and scientists who strive to m ake a difference through careers that combine discovery, education, and clinical care. In pursuit of this mission, the ANA introduces a new podcast series, AN...